Curis, Inc. (CRIS)
1.35
-0.02
(-1.46%)
USD |
NASDAQ |
Sep 04, 16:00
1.36
+0.01
(+0.74%)
After-Hours: 20:00
Curis Price : 1.35 for Sept. 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 04, 2026 | 1.37 | 1.39 | 1.30 | 1.35 | 96907.00 |
| Sep 03, 2026 | 1.42 | 1.42 | 1.35 | 1.37 | 126042.0 |
| Sep 02, 2026 | 1.46 | 1.475 | 1.38 | 1.38 | 85272.00 |
| Sep 01, 2026 | 1.45 | 1.472 | 1.40 | 1.42 | 65424.00 |
| Aug 31, 2026 | 1.48 | 1.53 | 1.408 | 1.49 | 35842.00 |
| Aug 28, 2026 | 1.51 | 1.58 | 1.45 | 1.49 | 119833.0 |
| Aug 27, 2026 | 1.56 | 1.589 | 1.40 | 1.50 | 288289.0 |
| Aug 26, 2026 | 1.59 | 1.610 | 1.51 | 1.54 | 105410.0 |
| Aug 25, 2026 | 1.61 | 1.64 | 1.55 | 1.59 | 142438.0 |
| Aug 24, 2026 | 1.60 | 1.65 | 1.511 | 1.58 | 83105.00 |
| Aug 21, 2026 | 1.63 | 1.660 | 1.50 | 1.58 | 212508.0 |
| Aug 20, 2026 | 1.71 | 1.715 | 1.59 | 1.61 | 133880.0 |
| Aug 19, 2026 | 1.72 | 1.75 | 1.65 | 1.72 | 196454.0 |
| Aug 18, 2026 | 1.83 | 1.93 | 1.68 | 1.70 | 282117.0 |
| Aug 17, 2026 | 2.03 | 2.03 | 1.752 | 1.80 | 367791.0 |
| Aug 14, 2026 | 1.83 | 2.08 | 1.74 | 1.80 | 470549.0 |
| Aug 13, 2026 | 1.58 | 2.08 | 1.54 | 1.87 | 2.293M |
| Aug 12, 2026 | 2.33 | 2.40 | 1.63 | 1.67 | 1.147M |
| Aug 11, 2026 | 3.20 | 3.37 | 2.29 | 2.31 | 600781.0 |
| Aug 10, 2026 | 4.07 | 4.15 | 3.500 | 3.66 | 72953.00 |
| Aug 07, 2026 | 4.35 | 4.35 | 3.955 | 4.02 | 70018.00 |
| Aug 06, 2026 | 4.49 | 4.700 | 4.02 | 4.41 | 78957.00 |
| Aug 05, 2026 | 4.84 | 5.063 | 4.39 | 4.545 | 54587.00 |
| Aug 04, 2026 | 5.14 | 5.280 | 4.613 | 4.72 | 85578.00 |
| Aug 03, 2026 | 5.13 | 5.50 | 5.06 | 5.15 | 84506.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 8.24 |
| Amgen, Inc. | 437.23 |
| Anika Therapeutics, Inc. | 20.81 |
| BioCryst Pharmaceuticals, Inc. | 9.96 |
| Imunon, Inc. | 1.58 |
Price Related Metrics
| PS Ratio | 0.3658 |
| Price to Book Value | 0.5604 |
| Earnings Yield | -1.06K% |
| Market Cap | 2.631M |